Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alkermes
3
×
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
national top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
glaxosmithkline
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
svb leerink
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
3b pharmaceuticals
abbvie
abeona therapeutics
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
What
roundup
according
akcea
alkermes
antipsychotic
benefits
bio
biopharma
biotech
cases
caveats
centers
cigarettes
commonly
congress
congressional
control
crispr
deaths
designed
disease
drug
effect
electronic
executives
favor
fda
feud
gain
group
including
injuries
isn’t
known
later
linked
lung
medicine
month
nash
Language
unset
Current search:
alkermes
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More